Brooks Laboratories Limited Market Cap ($20.86 Million)
Market Cap & Net Worth: Brooks Laboratories Limited (BROOKS)
Brooks Laboratories Limited market cap. Brooks Laboratories Limited (NSE:BROOKS) has a market capitalization of $20.86 Million (Rs1.93 Billion) as of November 5, 2026. Listed on the NSE stock exchange, this India-based company holds position #24821 globally and #1373 in its home market, demonstrating a 9.66% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Brooks Laboratories Limited's stock price Rs65.49 by its total outstanding shares 29457248 (29.46 Million). Also see BROOKS operating cash flow for how efficiently the company converts equity into cash flow.
Brooks Laboratories Limited Market Cap History (2015–2026)
Brooks Laboratories Limited market cap history from 2015 to 2026. Data shows change from $29.47 Million to $20.86 Million (-1.15% CAGR). Check Brooks Laboratories Limited stock price for real-time trading data and today's change.
Brooks Laboratories Limited Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Brooks Laboratories Limited's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore BROOKS year-over-year net asset growth to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
0.03x
Brooks Laboratories Limited's market cap is 0.03 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $42.21 Million | $800.09 Million | $106.33 Million | 0.05x | 0.40x |
| 2017 | $35.89 Million | $575.40 Million | $19.57 Million | 0.06x | 1.83x |
| 2018 | $19.34 Million | $557.12 Million | -$138.13 Million | 0.03x | N/A |
| 2019 | $9.24 Million | $550.30 Million | -$148.05 Million | 0.02x | N/A |
| 2020 | $21.17 Million | $691.33 Million | -$243.76 Million | 0.03x | N/A |
| 2021 | $31.62 Million | $770.68 Million | -$193.75 Million | 0.04x | N/A |
| 2022 | $34.82 Million | $911.85 Million | -$193.13 Million | 0.04x | N/A |
| 2023 | $45.75 Million | $624.80 Million | -$209.00 Million | 0.07x | N/A |
| 2024 | $57.39 Million | $794.86 Million | -$195.92 Million | 0.07x | N/A |
| 2025 | $25.53 Million | $825.57 Million | -$99.67 Million | 0.03x | N/A |
Competitor Companies of BROOKS by Market Capitalization
Companies near Brooks Laboratories Limited in the global market cap rankings as of November 5, 2026. Also see total assets of Brooks Laboratories Limited for a full breakdown of the balance sheet.
Key companies related to Brooks Laboratories Limited by market ranking:
- Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #514 globally with a market cap of $52.60 Billion USD.
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #538 globally with a market cap of $50.42 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #588 globally with a market cap of $45.79 Billion USD ( CN¥312.89 Billion CNY).
- Takeda Pharmaceutical Company Limited (F:TKDA): Ranked #621 globally with a market cap of $43.60 Billion USD ( €37.29 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #514 | Takeda Pharmaceutical Co Ltd ADR | NYSE:TAK | $52.60 Billion | $16.65 |
| #538 | GALDERMA GROUP AG | NYSE:GALDY | $50.42 Billion | $47.80 |
| #588 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $45.79 Billion | CN¥49.05 |
| #621 | Takeda Pharmaceutical Company Limited | F:TKDA | $43.60 Billion | €18.50 |
Market Capitalization of Brooks Laboratories Limited (2015–2026)
Market capitalization of Brooks Laboratories Limited from 2015 to today. Between 2015 and today, Brooks Laboratories Limited's market cap moved from $29.47 Million to $ 20.86 Million, with a yearly change of -1.15%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | Rs20.86 Million | -18.28% |
| 2025 | Rs25.53 Million | -55.51% |
| 2024 | Rs57.39 Million | +25.45% |
| 2023 | Rs45.75 Million | +31.38% |
| 2022 | Rs34.82 Million | +10.13% |
| 2021 | Rs31.62 Million | +49.36% |
| 2020 | Rs21.17 Million | +129.14% |
| 2019 | Rs9.24 Million | -52.22% |
| 2018 | Rs19.34 Million | -46.12% |
| 2017 | Rs35.89 Million | -14.98% |
| 2016 | Rs42.21 Million | +43.24% |
| 2015 | Rs29.47 Million | -- |
End of Day Market Cap According to Different Sources
On Nov 5th, 2026 the market cap of Brooks Laboratories Limited was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $20.86 Million USD |
| MoneyControl | $20.86 Million USD |
| MarketWatch | $20.86 Million USD |
| marketcap.company | $20.86 Million USD |
| Reuters | $20.86 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Brooks Laboratories Limited
Brooks Laboratories Limited provides contract development and manufacturing services for pharmaceutical companies in India and internationally. The company's product portfolio includes liquid injection ampoules and vials, dry powder injection vials, lyophilized injections, eye/ear drops, and nasal drops; B-Lactam and cephalosporin tablets, dry powder syrups, and injections; general, liquid, and d… Read more